Determined to foster health research in Nigeria, MTN Foundation has collaborated with the Nigerian Institute of Medical Research (NIMR) to establish an Oligo Synthesis laboratory.
This partnership according to MTN Foundation will go a long way in the area of medical development in Nigeria as well as make provision for supportive infrastructure and environments for healthcare research and training.
Dennis Okoro, Director, MTN Foundation, reiterated MTN’s commitment to supporting public developmental initiatives. He said, “At the core of what we do is collaborating with public and private sector partners to provide solutions that alleviate some of the pressing issues facing our society. We embarked on this project with the goal of improving the quality of life of Nigerians.
Okoro stated this when Members of the Board of paid a courtesy visit to the Nigerian Institute of Medical Research (NIMR). Adding that this is in furtherance of its commitment to partnering with relevant institutions in.
Delegation from the MTN Foundation included Director, MTN Foundation, Mrs Aishatu Sadauki; Director, MTN Foundation, Hon. Reginald Okeya; Director, MTN Foundation, Mr Dennis Okoro; and Executive Secretary, MTN Foundation, Odunayo Sanya. They were received by the Director-General, NIMR, Prof. Babatunde Lawal Salako and Director of Administration, NIMR, Abdullahi Yunusazazzau
Key areas of discussion include progress report on the synthesised Oligonucleotides, sustainability plans, applications in vaccine and drug development, and health development initiatives that seek to position Nigeria as the centre of health innovation in the continent.
And now that we have perfected the production of primers, in the next few weeks, we will open our market to the world. We applaud MTN for highlighting the expertise of Nigerian researchers in medical diagnostics and creation of experimental vaccines.’’
In August 2021, MTN Nigeria through its foundation donated Oligo-synthesizer equipment to the NIMR to aid the local development of primers for indigenous production of test kits for Covid-19 and other diseases.